• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

与临床试验同时进行的经济分析。经济结果评估中的偏倚。

Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes.

作者信息

Ellwein L B, Drummond M F

机构信息

University of York.

出版信息

Int J Technol Assess Health Care. 1996 Fall;12(4):691-7. doi: 10.1017/s0266462300010977.

DOI:10.1017/s0266462300010977
PMID:9136476
Abstract

Clinical trial randomization schemes to control patient characteristics that can influence clinical response are not sufficient to control for their effects on operational efficiency and cost within the provider institution. This variation can result in biased economic findings when patients are allowed to select a provider themselves.

摘要

用于控制可能影响临床反应的患者特征的临床试验随机方案，不足以控制这些特征对医疗机构内部运营效率和成本的影响。当允许患者自行选择医疗机构时，这种差异可能导致有偏差的经济研究结果。

相似文献

1
Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes.与临床试验同时进行的经济分析。经济结果评估中的偏倚。
Int J Technol Assess Health Care. 1996 Fall;12(4):691-7. doi: 10.1017/s0266462300010977.
2
Economic evaluations and randomized trials in spinal disorders: principles and methods.脊柱疾病的经济学评估与随机试验：原理与方法
Spine (Phila Pa 1976). 2004 Feb 15;29(4):442-8. doi: 10.1097/01.brs.0000102683.61791.80.
3
Multisite randomized controlled trials in health services research: scientific challenges and operational issues.卫生服务研究中的多中心随机对照试验：科学挑战与操作问题
Med Care. 2001 Jun;39(6):627-34. doi: 10.1097/00005650-200106000-00010.
4
Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes.
Health Econ. 1993 Oct;2(3):205-12. doi: 10.1002/hec.4730020303.
5
Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.通过自助法提升成本效益分析：一种用于置信区间估计的非参数方法。
Health Econ. 1997 Jul-Aug;6(4):327-40. doi: 10.1002/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w.
6
Can resource use be extracted from randomized controlled trials to calculate costs? A review of smoking cessation interventions in general practice.
Int J Technol Assess Health Care. 1996 Fall;12(4):714-20. doi: 10.1017/s0266462300010990.
7
Considerations for the design and analysis of experimental studies in physical activity and exercise promotion: advantages of the randomised controlled trial.体育活动与运动促进实验研究的设计与分析考量：随机对照试验的优势
Br J Sports Med. 2000 Jun;34(3):220-4. doi: 10.1136/bjsm.34.3.220.
8
Analytic considerations in economic evaluations of multinational cardiovascular clinical trials.跨国心血管临床试验经济评估中的分析考量
Value Health. 2006 Sep-Oct;9(5):281-91. doi: 10.1111/j.1524-4733.2006.00117.x.
9
National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study.低患病率疾病研究中的全国概率样本。第一部分：来自艾滋病毒成本与服务利用研究的观点与经验教训。
Health Serv Res. 1999 Dec;34(5 Pt 1):951-68.
10
Design and analysis issues for economic analysis alongside clinical trials.与临床试验同时进行的经济分析的设计与分析问题。
Med Care. 2009 Jul;47(7 Suppl 1):S14-20. doi: 10.1097/MLR.0b013e3181a31971.

引用本文的文献

1
Using information and communication technologies (ICTs) to solve the repressed demand for primary dental care in the Brazilian Unified Health System due to the COVID-19 pandemic: a randomized controlled study protocol nested with a before-and-after study including economic analysis.利用信息和通信技术（ICTs）解决由于 COVID-19 大流行而导致巴西统一卫生系统中初级牙科保健需求受到抑制的问题：一项随机对照研究方案，嵌套了一项前后研究，包括经济分析。
BMC Oral Health. 2022 Apr 7;22(1):112. doi: 10.1186/s12903-022-02101-9.
2
Cost-Effectiveness of Community-to-Clinic Tailored Navigation for Colorectal Cancer Screening in an Underserved Population: Economic Evaluation Alongside a Group-Randomized Trial.社区到诊所的定制导航在服务不足人群中的结直肠癌筛查的成本效益：一项随机分组试验的经济评估。
Am J Health Promot. 2022 May;36(4):678-686. doi: 10.1177/08901171211068454. Epub 2022 Jan 27.
3
Cost-Effectiveness Analysis of Treatment Acute Deep Vein Thrombosis in Clinic of Vascular Surgery Sarajevo.萨拉热窝血管外科诊所治疗急性深静脉血栓形成的成本效益分析。
Open Access Maced J Med Sci. 2017 Aug 13;5(5):681-685. doi: 10.3889/oamjms.2017.139. eCollection 2017 Aug 15.
4
Evaluating the economics of complementary and integrative medicine.评估补充与整合医学的经济学情况。
Glob Adv Health Med. 2013 Mar;2(2):56-63. doi: 10.7453/gahmj.2013.002.
5
The role of fluoride in the preventive management of dentin hypersensitivity and root caries.氟化物在牙本质过敏症和根面龋的预防性管理中的作用。
Clin Oral Investig. 2013 Mar;17 Suppl 1(Suppl 1):S63-71. doi: 10.1007/s00784-012-0916-9. Epub 2012 Dec 28.
6
Applying health technology assessment to pharmaceutical care: pitfalls and future directions.将卫生技术评估应用于药学服务：陷阱与未来方向。
Pharm World Sci. 2005 Apr;27(2):73-5. doi: 10.1007/s11096-004-4098-7.
7
Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.聚乙二醇干扰素α-2b联合利巴韦林与干扰素α-2b联合利巴韦林用于初治慢性丙型肝炎的成本效益分析
Gut. 2003 Mar;52(3):425-32. doi: 10.1136/gut.52.3.425.
8
Design, analysis and presentation of multinational economic studies: the need for guidance.跨国经济研究的设计、分析与呈现：指导的必要性。
Pharmacoeconomics. 2002;20(2):75-90. doi: 10.2165/00019053-200220020-00001.
9
Testing the validity of cost-effectiveness models.检验成本效益模型的有效性。
Pharmacoeconomics. 2000 May;17(5):501-13. doi: 10.2165/00019053-200017050-00007.
10
Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.低分子量肝素治疗近端深静脉血栓形成的成本效益
J Gen Intern Med. 2000 Feb;15(2):108-15. doi: 10.1046/j.1525-1497.2000.03349.x.